肝硬化并发门静脉血栓临床表现和诊断进展

doi:10.3969/j.issn.1672-5069.2019.06.002

Abstract

Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis[J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.

[1] 苟园园,何松,吴开玲,等.肝硬化门静脉血栓160例的临床特点和治疗分析.中华消化杂志,2018,38(7):455-460.
[2] Tsochatzis EA, Senzolo M, Germani G, et al.Portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther, 2010,31:366-374.
[3] Rajani R, Bj rnsson E, Bergquist A, et al. The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment Pharmacol Ther, 2010,32:1154-1162.
[4] Yerdel MA, Gunson B, Mirza D, et al.Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation, 2000,69:1873-1881.
[5] de Franchis R, Baveno VI. Faculty expanding consensus in portal hypertension:Report of the Baveno VI Consensus Workshop:Stratifying risk and individualizing care for portal hypertension. J Hepatol, 2015,63:743-752.
[6] Sarin SK, Philips CA, Kamath PS.et al. Toward a comprehensive new classification of portal vein thrombosis in patients with cirrhosis. Gastroenterology, 2016,151:574-7.e3.
[7] Trebicka J, Strassburg CP.Etiology and complications of portal vein thrombosis. Viszeralmedizin,2014 , 30(6): 375-380.
[8] Kinjo N, Kawanaka H, Akahoshi T, et al.Portal vein thrombosis in liver cirrhosis. World J Hepatol, 2014,6:64-71.
[9] DeLeve LD,Valla DC,Garcia Tsao G. Vascular disorders of the liver.Hepatology,2009,49:1729-1764.
[10] European Association for the Study of the Liver. EASL Clinical Practice Guidelines: vascular diseases of the liver. J Hepatol, 2016,64:179-202.
[11] Hoekstra J, Janssen HL.Vascular liver disorders (II): portal vein thrombosis. Neth J Med, 2009,67:46-53.
[12] Sogaard KK, Astrup LB, Vilstrup H, et al.Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol, 2007,7:34.
[13] Plessier A, Rautou PE, Valla DC.Management of hepatic vascular diseases. J Hepatol, 2012,56(suppl 1):S25-38.
[14] Dell'Era A, Iannuzzi F, Fabris FM, et al. Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation. Dig Liver Dis, 2014,46:152-156.
[15] Dhiman RK, Behera A, Chawla YK, et al.Portal hypertensive biliopathy. Gut, 2007,56:1001-1008.
[16] Amitrano L, Guardascione MA, Brancaccio V, et al.Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol, 2004,40:736-741.
[17] Nery F, Chevret S, Condat B.et al.Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study. Hepatol Baltim Md, 2015,61:660-667.
[18] Chawla YK, Bodh V.Portal vein thrombosis. J Clin Exp Hepatol,2015,5:22-40.
[19] Berry K, Taylor J, Liou IW, et al.Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis. Clin Gastroenterol Hepatol, 2015,13:585-593.
[20] Maruyama H, Okugawa H, Takahashi M, et al.De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol, 2013,108:568-574.
[21] Luca A, Caruso S, Milazzo M, et al.Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology, 2012,265:124-132.
[22] Qi X, Yang Z, Fan D.Spontaneous resolution of portal vein thrombosis in cirrhosis:where do we stand, and where will we go Saudi J Gastroenterol, 2014,20:265-266.
[23] Qi X, Bai M, Yang Z, et al.Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis. Med Hypotheses, 2011,76:522-526.
[24] Ghabril M, Agarwal S, Lacerda M.et al.Portal vein thrombosis is a risk factor for poor early outcomes after liver transplantation: analysis of risk factors and outcomes for portal vein thrombosis in waitlisted patients. Transplantation, 2016,100:126-133.
[25] Chen H, Trilok G, Wang F, et al.A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors. Indian J Med Res, 2014,139:260-266.
[26] Amitrano L, Brancaccio V, Guardascione MA, et al.Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients:role of genetic thrombophilia. Endoscopy, 2002,34:535-538.
[27] European Association for the Study of the Liver.EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol, 2016, 64(1):179-202.
[28] Berzigotti A, Garcia-Criado A., Darnell A.Imaging in clinical decision-making for portal vein thrombosis. Nat Rev Gastroenterol Hepatol, 2014,11:308-316.
[29] Rossi S, Rosa L, Ravetta V.et al.Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. AJR, 2006,186:763-773.
[30] Qi X,Han G,He C,et a1.CT features of non-malignant ponal vein thrombosis:A pictorial review.Clin Res Hepatol Gastroenterol,2012,36(6):561-568.

Clinical manifestations and diagnosis of portal vein thrombosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Chen Shuai, Yang Changqing.. Pathogenesis and risk factors of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 761-764.
[2]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[3]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[4]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[5]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[6]	Zhang Rui, Wang Jian, Chen Shiyao.. Mechanism of portal vein thrombosis in cirrhotic patients with portal hypertension and the treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 930-933.
[7]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[8]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[9]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[10]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[11]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[12]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.
[13]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[14]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.
[15]	Bian Xinqu, Chen Jie, Liu Yanmin, et al. Serum thyroid hormone level changes in patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy [J]. Journal of Practical Hepatology, 2019, 22(5): 716-719.